ConductScience.org, home

Paper3976802

Natural course of retinitis pigmentosa over a three-year interval.

Berson EL and 4 others. Am J Ophthalmol, 1985. Cited by 271 papers, by iCite.

Cite this record

ConductScience Library. Natural course of retinitis pigmentosa over a three-year interval. Papers, record 3976802. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3976802

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Natural course of retinitis pigmentosa over a three-year interval.
PubMed
Journal
Am J Ophthalmol
PubMed
Year
1985
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
271
iCite
Relative citation ratio, by iCite
9.28
iCite
Revised in PubMed
2022-04-08
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Berson ELE L
2Sandberg MAM A
3Rosner BB
4Birch DGD G
5Hanson AHA H

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Retinitis PigmentosaMajor topic
Vision, OcularMajor topic
Adolescent
Adult
Child
Dark Adaptation
Electroretinography
Female
Fluorescein Angiography
Humans
Male
Middle Aged
Time Factors
Visual Acuity
Visual Fields

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
EY02014NEI NIH HHSUnited StatesU01EY002014PubMed and NIHNIH RePORTER
U10EY002014NIHNIH RePORTER

Download CSV of grants

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT01233609Trial of Oral Valproic Acid for Retinitis PigmentosaBackground

Source ClinicalTrials.gov

Download CSV of trials

Cited by114

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 271 citations.

PMIDTitleJournalYearIn PapersSource
42787486A 48-Month, Prospective, Multicenter, Natural History Study of Choroideremia.Ophthalmol Sci2026https://conductscience.org/library/papers/42787486PubMed
42668498Characterizing the non-pigmented retinitis pigmentosa in a Chinese cohort: Insights into phenotype, genotype, and disease progression.Adv Ophthalmol Pract Res2026https://conductscience.org/library/papers/42668498PubMed
42137601Single-cell and spatial transcriptomic analyses of gene therapy-associated retinal inflammation in non-human primates.Mol Ther Adv2026https://conductscience.org/library/papers/42137601PubMed
40261664PCARE-Associated Retinopathy - Genetics, Clinical Characteristics, and Natural History.Invest Ophthalmol Vis Sci2025https://conductscience.org/library/papers/40261664PubMed
39811267Longitudinal Assessment of Structural and Functional Changes in Rod-cone Dystrophy: A 10-year Follow-up Study.Ophthalmol Sci2025https://conductscience.org/library/papers/39811267PubMed
39627217Efficacy and safety of minocycline in retinitis pigmentosa: a prospective, open-label, single-arm trial.Signal Transduct Target Ther2024https://conductscience.org/library/papers/39627217PubMed
38140908Intraflagellar transport: A critical player in photoreceptor development and the pathogenesis of retinal degenerative diseases.Cytoskeleton (Hoboken)2024https://conductscience.org/library/papers/38140908PubMed
38133503Treatment Strategy With Gene Editing for Late-Onset Retinal Degeneration Caused by a Founder Variant in C1QTNF5.Invest Ophthalmol Vis Sci2023https://conductscience.org/library/papers/38133503PubMed
37713598Management of Retinitis Pigmentosa Via Wharton's Jelly-Derived Mesenchymal Stem Cells or Combination With Magnovision: 3-Year Prospective Results.Stem Cells Transl Med2023https://conductscience.org/library/papers/37713598PubMed
37696658Current Status of Clinical Trials Design and Outcomes in Retinal Gene Therapy.Cold Spring Harb Perspect Med2024https://conductscience.org/library/papers/37696658PubMed
37676679Spatial Cluster Patterns of Retinal Sensitivity Loss in Intermediate Age-Related Macular Degeneration Features.Transl Vis Sci Technol2023https://conductscience.org/library/papers/37676679PubMed
37525225A multidisciplinary approach to inherited retinal dystrophies from diagnosis to initial care: a narrative review with inputs from clinical practice.Orphanet J Rare Dis2023https://conductscience.org/library/papers/37525225PubMed
37261916Natural history of retinitis pigmentosa based on genotype, vitamin A/E supplementation, and an electroretinogram biomarker.JCI Insight2023https://conductscience.org/library/papers/37261916PubMed
37123408The double-edged sword of inflammation in inherited retinal degenerations: Clinical and preclinical evidence for mechanistically and prognostically impactful but treatable complications.Front Cell Dev Biol2023https://conductscience.org/library/papers/37123408PubMed
37113027New insights in the multimodal imaging of retinitis pigmentosa.Eur J Ophthalmol2024https://conductscience.org/library/papers/37113027PubMed
37108642Retinitis Pigmentosa: Current Clinical Management and Emerging Therapies.Int J Mol Sci2023https://conductscience.org/library/papers/37108642PubMed
37009075Anxiety and Depression in Patients With Retinitis Pigmentosa.J Vitreoretin Dis2021https://conductscience.org/library/papers/37009075PubMed
36840007Retinitis Pigmentosa: Novel Therapeutic Targets and Drug Development.Pharmaceutics2023https://conductscience.org/library/papers/36840007PubMed
36690461The Importance of Natural History Studies in Inherited Retinal Diseases.Cold Spring Harb Perspect Med2023https://conductscience.org/library/papers/36690461PubMed
36498452A Natural History Study of RP2-Related Retinopathy.J Clin Med2022https://conductscience.org/library/papers/36498452PubMed

See all 114 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3976802

GET https://conductscience.org/api/papers/v1/3976802/cited_by?page=2